Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety, tolerability and efficacy of RZ-001 in combination with valganciclovir for glioblastoma, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• RZ-001
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Rznomics, Inc. | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING